Skip to main content
Heather Lau, MD, Child Neurology, New York, NY

HeatherAnnLauMD

Child Neurology New York, NY

Director, NYU Lysosomal Storage Disorders Program

Overview of Dr. Lau

Dr. Heather Lau, MD is a Child Neurologist in New York, New York. She is currently licensed to practice medicine in New York.

Education & Training

  • NYU School of Medicine
    NYU School of MedicineFellowship, Child Neurology, 2007
  • NYU School of Medicine
    NYU School of MedicineFellowship, Neurogenetics, 2010 - 2011
  • NYU School of Medicine
    NYU School of MedicineResidency, Child Neurology, 2007 - 2010
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineResidency, Pediatrics, 2005 - 2007
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2005
  • New York Medical College
    New York Medical CollegeM.Sc., Biochemistry & Molecular Biology, 1998 - 2001
  • New York Medical College
    New York Medical CollegeMS, Biochemistry and Molecular Biology, -, 2001
  • Cornell University
    Cornell UniversityBS, Biology, Honors, 1994 - 1998
  • Cornell University
    Cornell UniversityB.S., General Biology, With honors, 1994 - 1998

Certifications & Licensure

  • null
    null, NY 2008 - 2023
  • NY State Medical License
    NY State Medical License 2008 - 2023
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Joseph Collins Fellowship for Medical Students University of Rochester School of Medicine & Dentistry, 2001
  • Research Honor’s Thesis Cornell University, 1998

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Multi-domain impact of elosufase alfa in Morquio A syndrome: assessments of tertiary endpoints from the pivotal phase III trial  
    Hendriksz CJ, Giugliani R, Harmatz P, Mengel E, Guffon N, Valayannopoulos V, Parini R Hughes D, Pastores GM, Lau HA, Al-Sayed MD; Raiman J, Jin D, STRIVE Investigat..., Mol Genet Metab, 9/6/2014
  • Shear-wave ultrasonography evaluation of human skeletal muscle in healthy subjects versus those with GNE-related myopathy  
    Carpenter E, Lau H, Kolodny E, Adler R, Radiology, 9/1/2014
  • Branching Enzyme Deficiency: Expanding the Clinical Spectrum  
    Paradas C, Akman HO, Ionete C, Lau H, Riskind PN, Jones DE, Smith TW, Hirano M, Dimauro S, JAMA Neurol, 11/18/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • A Controlled PHASE 2 Study of Sialic Acid-extended Release (SA-ER) IN GNE Myopathy
    Z. Argov, Y. Caraco, H. Lau, A. Pestronk, P. Shieh, A.M. Skrinar, J. Mayhew, J. Martinisi, E Kakkis, ICNMD, 7/1/2014
  • Oral Sialic Acid Extended Release (SA-ER) Stabilizes Upper Extremity Muscle Strength in Human GNE Myopathy: A Phase 2 Study
    Z. Argov, MD, Y. Caraco, MD, H. Lau, MD, A. Pestronk, MD, P. Shieh, MD, A. M. Skrinar,J. Mayhew, J. Martinisi and E. Kakkis, MD Ph.D., AAN, 5/1/2014
  • Longitudinal studies of brain structure and function in MPS disorders: a study of the lysosomal disease network
    Shapiro, Elsa; Delaney, Kathleen; King, Kelly; Nestrasil, Igor; Ahmed, Alia; Raiman, Julian; Harmatz, Paul; Lau, Heather; Shankar, Suma; Cowan, Morton; Whitley, Chester B, Molecular genetics & metabolism, 1/1/2014
  • Join now to see all

Lectures

  • Randomized controlled phase 2 study of GNE myopathy subjects treated with placebo, 6g or 3g doses of extended-release sialic acid (SA-ER) and an extension study at a ... 
    Berlin - 10/11/2014
  • GNE-related myopathy: Clinical presentation Of 16 Patients and Discussion of Emerging Therapies 
    1/1/2014
  • Spectrum of disease in Canavan 
    1/1/2014
  • Join now to see all

Press Mentions

  • How Stephen Hawking Was Able to Live for so Long with ALS
    How Stephen Hawking Was Able to Live for so Long with ALSMarch 14th, 2018

Professional Memberships